exRNAdisease

Entry Detail

---



General Information

Database ID: exR0269476 RNA Name: hsa-miR-193b-3p RNA Type: miRNA Chromosome: chr16 Starnd: + Coordinate: Start Site(bp): 14304017 End Site(bp): 14304038 External Links: hsa-miR-193b-3p

Disease Information

Disease Name: Multiple Sclerosis Disease Category: Nervous System Diseases MeSH ID: D009103 Type: Diseases Category/Nervous System Diseases Alias: Sclerosis, Multiple//Sclerosis, Disseminated//Disseminated Sclerosis//MS (Multiple Sclerosis)//Multiple Sclerosis, Acute Fulminating

Expression Detail

GEO ID: GSE140106 Description: Serum exosome microRNAs predict multiple sclerosis disease activity after fingolimod treatment Experimental Design: Fingolimod treatment Case Disease Type: Multiple Sclerosis Case Disease SubType: NA Case Sample: Fingolimod treated Multiple Sclerosis Control Sample: Untreated Number of Case: 27 Number of Control: 27 Number of Samples: 54

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand AFAP1 chr4 7758714 7939926 - ANTXR1 chr2 69013178 69249327 + EHD1 chr11 64851642 64888296 - LASP1 chr17 38869859 38921770 + LUZP1 chr1 23084023 23177808 - NUDT21 chr16 56429133 56452199 - RUSC1 chr1 155320894 155331114 + TSPAN14 chr10 80454166 80533124 + ZBTB5 chr9 37438102 37465450 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0001025 chr2 69565029 69565697 - lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC092295.2 chr19 36489649 36491040 + AC135050.6 chr16 31122235 31124064 + AL132780.1 chr14 22929607 22956374 + CYTOR chr2 87454781 87636740 + KCNQ1OT1 chr11 2608328 2699994 - LIMD1-AS1 chr3 45676369 45689200 - LINC01184 chr5 127939152 128083172 - MIR194-2HG chr11 64889560 64893449 - MIR4435-2HG chr2 111006015 111523376 - NEAT1 chr11 65422774 65445540 + XIST chrX 73820649 73852723 - ZFAS1 chr20 49278178 49299600 + Display:

Experiment Detail

GEO ID: GSE140106 Sample Source: Blood Source Fraction: Exosome Platform: GPL11154 Method: NGS Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1907 Sample treatment protocol: Exosomes were isolated from 1 mL RNase A (37 °C for 10 min; 100 ng/ml; Qiagen, Australia) treated serum, by size exclusion chromatography (qEV iZONE Science). RNA Extract protocol: Serum exosomes were processed for RNA extraction using the Plasma/Serum Circulating & Exosomal RNA Purification Mini Kit (Norgen Biotek, Cat. 51000) according to the manufacturer's protocol. RNA library preparation protocol: Exosome RNA sequencing libraries were then constructed using the NEBNext Multiplex Small RNA Library Prep Kit for Illumina (BioLabs, New England) according to the manufacturer's instructions.

Reference

PMID: 31721043 Title: Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment Author: Ebrahimkhani S, Beadnall HN, Wang C, Suter CM, Barnett MH, Buckland ME, Vafaee F Journal: Mol Neurobiol. 2020 Feb;57(2):1245-1258. Description: we sought the possible utility of serum exosome microRNAs as biomarkers for disease activity in multiple sclerosis patients in response to fingolimod therapy.